Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Division of Cancer Prevention Staff

Portrait of Eileen Dimond, RN, MS

Eileen Dimond, RN, MS

Nurse Consultant
Community Oncology and Prevention Trials Research Group
Division of Cancer Prevention
National Cancer Institute
9609 Medical Center Drive, Room 5E516
Rockville, MD 20850
Phone (240) 276-7086
Fax (240) 276-7847
  • Eileen Dimond is a nurse consultant in the Division of Cancer Prevention. She works with the NCI community oncology programs and the sites that form the community network across the U.S. and in Hawaii with a focus on clinical trial infrastructure and implementation in the community. She has over 20 years of experience as an advance practice nurse in the NCI's Intramural and Extramural programs with prior experience in medical oncology/transplant, cancer genetics, and health professional and patient communication and education about oncology clinical trials.

    She is a member of the Oncology Nursing Society, the American Society of Clinical Oncology and Sigma Theta Tau Nursing Honor Society. Her awards and recognition include the Excellence in Nursing Award, and the Superior Achievement in Nursing Award from the University of Scranton, Department of Nursing, where she received her Bachelor’s Degree; the ONS/Upjohn QOL award for her publication on the Nurse's Role in Advanced Directives; and the Distinguished Nurse Award, Clinical Center Department of Nursing. She has also received individual and group Merit awards for her work in clinical trial education for the public and health care professionals, and excellent service to the public respectively. She received her Master’s Degree in Nursing from the University of Maryland at Baltimore.

  • Underrepresented accrual into clinical trials

  • Programmatic infrastructure for effective trial implementation in the community

  • Cancer control (symptom management, quality of life, and prevention) trial development

Back to top